High Point, NC, United States of America

Tingwei Cai

This inventor holds 1 USPTO granted patent. Top assignee: Research Triangle Institute. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tingwei Cai. Retrieved from https://idiyas.com/inventor/tingwei-cai-ewqh5qf8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Tingwei Cai in Kappa Opioid Receptor Research

Introduction

Tingwei Cai is an accomplished inventor based in High Point, NC (US). He has made significant contributions to the field of pharmacology, particularly in the development of kappa opioid receptor ligands. His work focuses on addressing critical issues related to addiction and therapeutic interventions.

Latest Patents

Tingwei Cai holds a patent for kappa opioid receptor antagonists. These antagonists demonstrate substantial improvements in functional binding assays to kappa opioid receptors. The implications of his patent are profound, as they offer potential treatments for disease states that can be ameliorated by binding to the kappa opioid receptor, such as heroin and cocaine addictions.

Career Highlights

Cai is associated with the Research Triangle Institute, where he continues to advance his research. His work is characterized by a commitment to innovation and a focus on practical applications of his findings in the medical field.

Collaborations

Tingwei Cai has collaborated with notable colleagues, including Frank Ivy Carroll and Hernan A Navarro. These partnerships enhance the scope and impact of his research endeavors.

Conclusion

Tingwei Cai's contributions to the field of kappa opioid receptor research highlight his innovative spirit and dedication to addressing addiction. His patent represents a significant step forward in developing effective treatments for individuals struggling with substance use disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…